Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment

BACKGROUND: In Japan, intravitreal anti-vascular endothelial growth factor (anti-VEGF) dosing regimens for wet age-related macular degeneration (wAMD) include pro re nata, every 2 months, and treat-and-extend, resulting in different outcomes and patient burden. Although reflecting patient preference...

Descripción completa

Detalles Bibliográficos
Autores principales: Joko, Takeshi, Nagai, Yoshimi, Mori, Ryusaburo, Tanaka, Koji, Oshima, Yuji, Hikichi, Yusuke, Komori, Tetsushi, Carrasco, Joao, Maculaitis, Martine C, Will, Oliver, Beusterien, Kathleen, Takahashi, Kanji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082633/
https://www.ncbi.nlm.nih.gov/pubmed/32214802
http://dx.doi.org/10.2147/PPA.S228890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082633/
https://www.ncbi.nlm.nih.gov/pubmed/32214802
http://dx.doi.org/10.2147/PPA.S228890

Ejemplares similares